BillionToOne, Inc. BLLN
$102.19
▲ +1.48% 24H
About
BillionToOne, Inc. is a precision diagnostics company specializing in the development of advanced molecular diagnostic tests for healthcare applications. The company’s core innovation is its proprietary single-molecule next-generation sequencing (smNGS) platform, which enables highly sensitive and accurate detection an…
SectorHealthcare
ExchangeNASDAQ
IndustryDiagnostics & Research
CountryUnited States
Employees713
TickerBLLN
Statistics
Market Cap$4.70B
Revenue (TTM)$305.1M
Net Income$7.5M
Net Margin2.4%
EPS$0.14
P/E180.47
P/S12.88
P/B9.03
EV/EBITDA96.97
ROE8.7%
Dividend Yield—
Price$102.19
Data: Twelve Data · Revenue = mcap / P/S